2003.4000 -1.00 (-0.05%)
NSE Sep 23, 2025 12:09 PM
Volume: 111.6K
 

2003.40
-0.05%
Chola Wealth Direct
Background: Amongst the largest Pharma companies in domestic market with Net Sales of INR 112.9bn with a strong brand portfolio. R&D; cost is in excess of 8% of Sales. Exports account for 73% with Developed Markets (DM) at 58% and EM at 15%. Sales Mix: API - 10%, Domestic Formulations - 25%, DM Formulations - 56%, EM Formulations - 9%. Historically strong in anti-TB segment, has built expertise in fermentation based products and segments like...
Lupin Ltd. has an average target of 2326.00 from 8 brokers.
More from Lupin Ltd.
Recommended